Metoprolol Succinate Tablet, Extended Release
Product Images NDC 67296-1902

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 67296-1902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (118706c2 F03f 4175 Aba2 4f0cddb75ae7 01)

Chemical structure depicted representing the active ingredient metoprolol succinate in the product metoprolol succinate extended-release tablets, 50 mg by Redpharm Drug.*

FDA Label Image

Figure (118706c2 F03f 4175 Aba2 4f0cddb75ae7 02)

A forest plot chart depicting subgroup results from the MERIT-HF study for metoprolol succinate. The chart presents relative risk and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure across various patient subgroups including geographic region, NYHA class, ejection fraction, ischemic etiology, sex, race, history of myocardial infarction, diabetes, hypertension, and heart rate.*

FDA Label Image

Figure (118706c2 F03f 4175 Aba2 4f0cddb75ae7 03)

Label for metoprolol succinate extended-release tablets, USP, showing a strength of 25 mg. The label includes manufacturer Zydus Lifesciences Ltd. and distributor Zydus Pharmaceuticals (USA) Inc. It states the package contains 100 tablets and is Rx only. The label displays storage instructions and cautionary notes.*

FDA Label Image

Figure (118706c2 F03f 4175 Aba2 4f0cddb75ae7 04)

Metoprolol Succinate 50 mg extended-release tablets label showing 100 count bottle size. The label includes the proprietary name, generic name, and strength prominently. It states Rx only and is manufactured by Zydus Lifesciences Ltd., distributed by Zydus Pharmaceuticals (USA) Inc. The label features storage instructions, dosage notes, and a barcode on the left side.*

FDA Label Image

Figure (118706c2 F03f 4175 Aba2 4f0cddb75ae7 05)

Metoprolol Succinate Extended-Release Tablets USP 100 mg label showing a bottle label with the brand Zydus. The label includes the NDC 68382-566-01, dosage strength 100 mg, package size of 100 tablets, and states Rx only. Storage and dispensing instructions, manufacture by Zydus Lifesciences Ltd., and distribution by Zydus Pharmaceuticals (USA) Inc. are visible.*

FDA Label Image

Figure (118706c2 F03f 4175 Aba2 4f0cddb75ae7 06)

Label for Metoprolol Succinate Extended-Release Tablets USP, 200 mg strength, supplied as 100 tablets per package. The label shows the NDC 68382-567-01 and indicates the product is Rx only. Manufacturer is Zydus Lifesciences Ltd., India, and distributor is Zydus Pharmaceuticals (USA) Inc., Pennington, NJ. The label includes storage instructions and a barcode on the left.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.